Vengalil Krishna K. Chatterjee, FRCP

NIHR Cambridge Clinical Research Facility
Cambridge, England, United Kingdom

Disclosure information not submitted.

Presentation(s):

• 219 - Safety and Immunogenicity of BNT166a, an Investigational Quadrivalent mRNA Mpox Vaccine

  Monday, October 20, 2025
  3:27 PM - 3:39 PM US ET